Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 14,063,642 $ 10,574,292
Prepaid expenses and other current assets 460,917 54,537
Australia research and development incentives receivable 255,306 43,666
Total current assets 14,779,865 10,672,495
Deferred offering costs 651,582
Other assets 2,800 3,122
Total assets 14,782,665 11,327,199
Current liabilities:    
Accounts payable 1,019,093 960,401
Accrued expenses 1,437,200 1,185,595
Total current liabilities and total liabilities 2,456,293 2,145,996
Commitments and contingencies
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 and 70,000,000 shares authorized at September 30, 2022 and December 31, 2021 respectively, 0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 and 30,000,000 shares authorized at September 30, 2022 and December 31, 2021 respectively, 10,945,904 and 7,584,980 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 1,095 758
Additional paid-in capital 51,467,127 37,618,438
Accumulated deficit (39,090,204) (28,437,993)
Accumulated other comprehensive income (loss) (51,646)
Total stockholders' equity 12,326,372 9,181,203
Total liabilities and stockholders' equity $ 14,782,665 $ 11,327,199